Sartorius Stedim Biotech S.A.
SDMHF
$235.80
$0.800.34%
OTC PK
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | 50.79% | 11.76% | 0.22% | -64.41% | |
| Total Depreciation and Amortization | 10.26% | -0.21% | 1.14% | 46.17% | |
| Total Amortization of Deferred Charges | -- | 77.05% | -- | -- | |
| Total Other Non-Cash Items | -31.76% | -71.79% | 1,730.90% | 196.93% | |
| Change in Net Operating Assets | -253.05% | -15.87% | 12,973.04% | 107.28% | |
| Cash from Operations | -39.11% | -16.04% | 165.35% | 46.10% | |
| Capital Expenditure | 0.21% | 22.95% | 34.70% | 45.72% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 91.75% | -- | -- | |
| Cash from Investing | -1.11% | 24.52% | 96.95% | 53.02% | |
| Total Debt Issued | -5.15% | -- | -100.00% | -74.58% | |
| Total Debt Repaid | 100.00% | 91.91% | 85.19% | -4,721.67% | |
| Issuance of Common Stock | -- | 55.56% | 93.75% | -- | |
| Repurchase of Common Stock | -- | -- | -- | -293.33% | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -5.44% | -- | -- | -- | |
| Other Financing Activities | 99.27% | 91.47% | -10,991.67% | -298.55% | |
| Cash from Financing | 85.06% | 94.72% | -107.26% | -1,051.40% | |
| Foreign Exchange rate Adjustments | -251.48% | 667.42% | 133.67% | -11.24% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 96.32% | 1,024.07% | 369.04% | -1,589.43% | |